Showing results (11-20 of 71) with videos related to
Sort By:
Pageof 8
Current Pharmaceutical Biotechnology|January 12, 2024
Simultaneous Determination of Levo-tetrahydropalmatine and Naltrexone in Rat Plasma by LC-MS/MS and its Application in a Pharmacokinetic StudyKun Feng, Sherwin K B Sy, Mingming Yu, et al.Antimicrobial Agents and Chemotherapy|December 4, 2013
Estimation of intracellular concentration of stavudine triphosphate in HIV-infected children given a reduced dose of 0.5 milligrams per kilogram twice dailySherwin K B Sy, Steve Innes, Hartmut Derendorf, et al.The AAPS Journal|August 31, 2013
A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantationSherwin K B Sy, Jules Heuberger, Sireen Shilbayeh, et al.Planta Medica|January 23, 2020
Pharmacokinetics, Pharmacodynamics and Dermal Distribution of 5-Methoxypsoralen Based on a Physiologically Based Pharmacokinetic Model to Support Phytotherapy Using Brosimum gaudichaudiiFrederico Severino Martins, Sherwin K B Sy, Maria José Vieira Fonseca, et al.The Journal of Antimicrobial Chemotherapy|December 26, 2015
Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic/pharmacodynamic modelLuning Zhuang, Yang He, Huiming Xia, et al.Clinical Pharmacology in Drug Development|May 4, 2016
Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainmentSireen A R Shilbayeh, Sherwin K B Sy, Murad Melhem, et al.Cancer Chemotherapy and Pharmacology|March 23, 2018
Integrated population pharmacokinetics of etirinotecan pegol and its four metabolites in cancer patients with solid tumorsSherwin K B Sy, Yen Lin Chia, Toufigh Gordi, et al.Clinical Pharmacology in Drug Development|April 29, 2016
Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Transplant PatientsSherwin K B Sy, Rajendra P Singh, Sireen Shilbayeh, et al.British Journal of Clinical Pharmacology|April 2, 2023
Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populationsFrederico Severino Martins, José Eduardo Severino Martins, Patricia Severino, et al.European Journal of Clinical Pharmacology|March 12, 2011
Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milkSam Salman, Sherwin K B Sy, Kenneth F Ilett, et al.Pageof 8